| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.008 | 1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |